RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
BioSig Technologies - Stock

BioSig Technologies EBIT 2024

BioSig Technologies EBIT

-6.94 M USD

Ticker

BSGM

ISIN

US09073N2018

WKN

A2N5TW

In 2024, BioSig Technologies's EBIT was -6.94 M USD, a -75.67% increase from the -28.51 M USD EBIT recorded in the previous year.

The BioSig Technologies EBIT history

YEAREBIT (undefined USD)
2026e-
2025e-
2024e-
2023-
2022-
2021-
2020-
2019-
2018-
2017-
2016-
2015-
2014-
2013-
2012-
2011-

BioSig Technologies Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into BioSig Technologies, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by BioSig Technologies from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects BioSig Technologies’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of BioSig Technologies. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into BioSig Technologies’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing BioSig Technologies’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on BioSig Technologies’s growth potential.

BioSig Technologies Revenue, Profit, and EBIT History

DateBioSig Technologies RevenueBioSig Technologies EBITBioSig Technologies Net Income
2026e123.81 M undefined-26.29 M undefined-8.37 M undefined
2025e510,000 undefined-12.55 M undefined-12.82 M undefined
2024e0 undefined-6.94 M undefined-8.79 M undefined
202318,000 undefined-28.51 M undefined-29.05 M undefined
2022286,000 undefined-27.27 M undefined-27.27 M undefined
2021441,000 undefined-33.41 M undefined-31.93 M undefined
20200 undefined-59.18 M undefined-52.23 M undefined
20190 undefined-34.6 M undefined-34.08 M undefined
20180 undefined-17.26 M undefined-18.14 M undefined
20170 undefined-12.91 M undefined-12.82 M undefined
20160 undefined-11.16 M undefined-11.7 M undefined
20150 undefined-12.04 M undefined-9.81 M undefined
20140 undefined-7.87 M undefined-8.77 M undefined
20130 undefined-6.24 M undefined-10.1 M undefined
20120 undefined-2.26 M undefined-2.48 M undefined
20110 undefined-1.07 M undefined-1.18 M undefined

BioSig Technologies stock margins

The BioSig Technologies margin analysis displays the gross margin, EBIT margin, as well as the profit margin of BioSig Technologies. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for BioSig Technologies.

  • 3 years

  • 5 years

  • 10 years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the BioSig Technologies's sales revenue. A higher gross margin percentage indicates that the BioSig Technologies retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the BioSig Technologies's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the BioSig Technologies's total revenue generated. When comparing the revenue margin year over year, investors can gauge the BioSig Technologies's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the BioSig Technologies. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the BioSig Technologies's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

BioSig Technologies Margin History

BioSig Technologies Gross marginBioSig Technologies Profit marginBioSig Technologies EBIT marginBioSig Technologies Profit margin
2026e100 %-21.23 %-6.76 %
2025e100 %-2,460 %-2,513.36 %
2024e100 %0 %0 %
2023100 %-158,400 %-161,388.89 %
202280.07 %-9,533.22 %-9,535.31 %
202154.88 %-7,576.19 %-7,239.46 %
2020100 %0 %0 %
2019100 %0 %0 %
2018100 %0 %0 %
2017100 %0 %0 %
2016100 %0 %0 %
2015100 %0 %0 %
2014100 %0 %0 %
2013100 %0 %0 %
2012100 %0 %0 %
2011100 %0 %0 %

BioSig Technologies Aktienanalyse

What does BioSig Technologies do?

Biosig Technologies Inc is a medical technology company based in New York, specializing in the development of advanced electrophysiological (EP) instruments and accessories for use in hospitals and clinics. The company was founded in 2009 and successfully went public in June 2018. The main task of Biosig Technologies is to provide doctors and medical professionals with helpful instruments that simplify the difficult work of EP tests and ablations. The development of EP instruments typically requires high specialization, as knowledge of both electrophysiology and engineering is required. However, Biosig has already gained a high level of expertise in this field and has established itself as a leading company in the industry. Biosig Technologies' business model is based on selling EP instruments and accessories to hospitals and clinics in the US and international markets. The products include the "PURE EP System," an electrophysiological signal processing and recording system specifically designed for use in EP tests and ablations. The "PURE EP System" allows doctors to obtain accurate information about the electrical activity of the heart in order to improve the diagnosis and treatment of cardiac arrhythmias. The "PURE EP System" has proven its excellence in practice and is successfully used by many clinics and hospitals in the US. The system offers higher sensitivity and accuracy than conventional electrophysiological instruments, enabling better differentiation and representation of signals originating from different heart tissues. This allows doctors to make more accurate diagnoses and develop more targeted treatment strategies. Biosig Technologies offers a wide range of products and services tailored to the needs of customers in various areas of healthcare. The company also provides excellent customer support and training to ensure that users properly utilize the instruments and maximize their benefits. In addition to the EP field, the company is also exploring the use of the technology in other areas of medicine. Biosig Technologies actively works on the development of instruments to improve respiratory monitoring and facilitate the use of robots in surgery. The company plans to bring more instruments and accessories to the market in the future to expand its portfolio and meet additional customer needs. Biosig Technologies is a dynamic company with a high degree of innovation and a strong focus on the needs of doctors and medical professionals. The company aims to improve healthcare by providing advanced instruments and accessories, making a positive contribution to society. BioSig Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing BioSig Technologies's EBIT

BioSig Technologies's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of BioSig Technologies's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

BioSig Technologies's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in BioSig Technologies’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about BioSig Technologies Stock

How much did BioSig Technologies achieve in EBIT for the current year?

In the current year, BioSig Technologies has achieved an EBIT of -6.94 M USD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company BioSig Technologies.

How has the EBIT of BioSig Technologies developed in recent years?

The EBIT of BioSig Technologies has increased by -75.673% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company BioSig Technologies?

The EBIT of BioSig Technologies is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does BioSig Technologies pay?

Over the past 12 months, BioSig Technologies paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, BioSig Technologies is expected to pay a dividend of 0 USD.

What is the dividend yield of BioSig Technologies?

The current dividend yield of BioSig Technologies is .

When does BioSig Technologies pay dividends?

BioSig Technologies pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of BioSig Technologies?

BioSig Technologies paid dividends every year for the past 0 years.

What is the dividend of BioSig Technologies?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is BioSig Technologies located?

BioSig Technologies is assigned to the 'Health' sector.

Wann musste ich die Aktien von BioSig Technologies kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of BioSig Technologies from 6/19/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 6/19/2024.

When did BioSig Technologies pay the last dividend?

The last dividend was paid out on 6/19/2024.

What was the dividend of BioSig Technologies in the year 2023?

In the year 2023, BioSig Technologies distributed 0 USD as dividends.

In which currency does BioSig Technologies pay out the dividend?

The dividends of BioSig Technologies are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von BioSig Technologies

Our stock analysis for BioSig Technologies Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioSig Technologies Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.